4//SEC Filing
Trapp Todd A 4
Accession 0001179110-21-009900
CIK 0000815094other
Filed
Nov 4, 8:00 PM ET
Accepted
Nov 5, 4:28 PM ET
Size
13.8 KB
Accession
0001179110-21-009900
Insider Transaction Report
Form 4
ABIOMED INCABMD
Trapp Todd A
Vice President, CFO
Transactions
- Award
Common Stock, $0.01 par value
2021-11-03+6,975→ 16,612 total - Tax Payment
Common Stock, $0.01 par value
2021-11-03$349.76/sh−1,549$541,778→ 15,063 total
Holdings
- 7,000
Stock Option (Right to Buy)
Exercise: $266.39From: 2020-05-30Exp: 2029-05-30→ Common Stock (0 underlying) - 6,530
Stock Option (right to buy)
Exercise: $223.90From: 2021-05-29Exp: 2030-05-29→ Common Stock (0 underlying) - 3,737
Stock Option (right to buy)
Exercise: $283.88From: 2022-05-25Exp: 2031-05-25→ Common Stock (0 underlying)
Footnotes (4)
- [F1]Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
- [F2]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- [F3]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- [F4]Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on November 5, 2020. One half of these restricted stock units vested on November 3, 2021 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone with the remaining vesting on the second anniversary of the date of grant as long as the reporting person continues to be employed by the issuer on the vesting dates.
Documents
Issuer
ABIOMED INC
CIK 0000815094
Entity typeother
Related Parties
1- filerCIK 0001638242
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 8:00 PM ET
- Accepted
- Nov 5, 4:28 PM ET
- Size
- 13.8 KB